Price T Rowe Associates Inc Rhythm Pharmaceuticals, Inc. Transaction History

Price T Rowe Associates Inc

$816 Billion
Q1 2024

A detailed history of Price T Rowe Associates Inc transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 481,533 shares of RYTM stock, worth $19.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

481,533

Previous 572,297 15.86%

Holding current value

$19.8 Million

Previous $26.3 Million 20.69%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$39.12 - $52.44 $3.55 Million - $4.76 Million	-90,764 Reduced 15.86%	481,533 $20.9 Million
Q4 2023 Feb 14, 2024	BUY	$21.39 - $49.64 $7.74 Million - $18 Million	361,945 Added 172.07%	572,297 $26.3 Million
Q3 2023 Nov 14, 2023	SELL	$15.81 - $27.8 $203,711 - $358,203	-12,885 Reduced 5.77%	210,352 $4.82 Million
Q2 2023 Aug 14, 2023	BUY	$16.32 - $21.15 $843,042 - $1.09 Million	51,657 Added 30.11%	223,237 $3.68 Million
Q1 2023 May 15, 2023	BUY	$16.88 - $34.24 $2.66 Million - $5.39 Million	157,380 Added 1108.31%	171,580 $3.06 Million

Q4 2022 Feb 14, 2023	SELL	$22.25 - $30.25 $46,725 - $63,525	-2,100 Reduced 12.88%	14,200 $414,000
Q3 2022 Nov 14, 2022	BUY	$4.3 - $30.85 $70,090 - $502,855	16,300 New	16,300 $400,000
Q2 2022 Aug 15, 2022	SELL	$3.12 - $12.25 $40,248 - $158,025	-12,900 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$6.13 - $12.24 $79,077 - $157,896	12,900 New	12,900 $149,000
Q4 2021 Feb 14, 2022	SELL	$8.62 - $13.9 $144,057 - $232,296	-16,712 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$18.52 - $22.55 $23,094 - $28,119	1,247 Added 8.06%	16,712 $327,000
Q1 2021 May 17, 2021	BUY	$20.25 - $39.49 $3,948 - $7,700	195 Added 1.28%	15,465 $329,000
Q4 2020 Feb 16, 2021	BUY	$21.17 - $32.61 $323,265 - $497,954	15,270 New	15,270 $454,000

Others Institutions Holding RYTM

# of Institutions

176

Shares Held

62.4M

Call Options Held

880K

Put Options Held

84.1K

View Full List

About RHYTHM PHARMACEUTICALS, INC.

Ticker RYTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,720,000
Market Cap $2.29B
Description
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...

More about RYTM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Rhythm Pharmaceuticals, Inc. Transaction History